Document Detail


Platelet high-density lipoprotein activates transferrin-derived phagocytosis activators, MAPPs, following thrombin digestion.
MedLine Citation:
PMID:  21194399     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Macromolecular activators of phagocytosis from platelets (MAPPs), transferrin-derived phagocytosis activators released from platelets, activate leukocytic phagocytosis via Fcγ receptors. It has been found that MAPPs can be prepared using stored platelets or their lysate. Using this artificial MAPP production system, it has been found that they can be produced from precursors (tetrameric and dimeric transferrins) following reaction with a low-molecular-weight (LMW) activator of MAPPs, which is liberated from a high-molecular-weight activator of MAPP (HMW activator) by reaction with thrombin. In this study, the HMW activator in platelet lysate was characterized by assaying phagocytosis of washed neutrophils. In an ultracentrifugation study of the platelet lysate, HMW activator activity was observed in the fraction corresponding to the density of high-density lipoprotein (HDL). The activity was observed in the apolipoproteins obtained from the HDL fraction. Among the apolipoproteins tested only apolipoprotein CIII showed the activity to produce MAPP in vitro. Affinity chromatography of the apolipoproteins from the HDL fraction of the platelet lysate using an anti-apolipoprotein CIII column revealed that the substance that binds with the antibody showed MAPP-forming activity. In a gel filtration study of thrombin-treated apolipoprotein CIII, a peak of LMW activator activity was observed for fractions with a molecular size smaller than that of apolipoprotein CIII. Finally, MAPP-forming activity of HDL obtained from the plasma was examined. MAPP was formed only when delipidized HDL was used. In conclusion, it is suggested that platelet HDL is the HMW activator and that this activation is achieved via apolipoprotein CIII after thrombin reaction in platelets.
Authors:
Haruhiko Sakamoto; Bin Wu; Yumiko Nagai; Sumiko Tanaka; Masayuki Onodera; Takafumi Ogawa; Masaki Ueno
Related Documents :
21378389 - Effects of intensive glucose control on platelet reactivity in patients with acute coro...
21513989 - Pkc isoenzymes in equine platelets and stimulus induced activation.
21232029 - Np-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with du...
21127289 - Protease-activated receptor signaling in platelets activates cytosolic phospholipase a2...
21115729 - Antiplatelet activity of valproic acid contributes to decreased soluble cd40 ligand pro...
10193209 - Formation of nitrogen-containing metabolites from the main iridoids of harpagophytum pr...
3554489 - Formation of prostacyclin-sensitive platelet aggregates in human whole blood in vitro. ...
7537639 - Role of protein kinase c in the anti-aggregatory effects of endothelin-1 on human plate...
344199 - Quantitative phagocytosis by human polymorphonuclear leucocytes. use of radiolabelled e...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-3
Journal Detail:
Title:  Platelets     Volume:  -     ISSN:  1369-1635     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9208117     Medline TA:  Platelets     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Inflammation Pathology, Department of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Kagawa, 761-0793, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Platelet membranes induce airway smooth muscle cell proliferation.
Next Document:  Online survey: knowledge about risks, prevention and consequences of infections with HBV among trave...